alexa New Strategies in the Treatment of Sepsis | OMICS International
ISSN: 2327-5073
Clinical Microbiology: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

New Strategies in the Treatment of Sepsis

Selcuk Kaya1 and Esin Yardim Kaya2*

1Karadeniz Technical University, School of Medicine, Department of Infectious Diseases and ClinicalMicrobiology, 61080, Trabzon, Turkey

2Ahi Evren Cardiovascular Surgery Education and Research Hospital, Department of Anesthesiology, Trabzon, Turkey

*Corresponding Author:
Esin Yardim Kaya
Ahi Evren Cardiovascular Surgery Education and Research Hospital
Department of Anesthesiology, Trabzon, Turkey
Tel: +904623775632
E-mail: [email protected]

Received Date: March 18, 2013; Accepted Date: April 25, 2013; Published Date: April 28, 2013

Citation: Kaya S, Kaya EY (2013) New Strategies in the Treatment of Sepsis. Clin Microbial 2:110. doi:10.4172/2327-5073.1000110

Copyright: © 2013 Kaya S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Clinical Microbiology: Open Access

Despite there being several important forms of treatment involving the early goal directed therapy and bundle implementations, a search for new options in the treatment of sepsis have been made inevitable by today’s persisting very high mortality rates. Some of these, such as antioxidant therapies and stem cell and gene therapies, are still in the experimental stages, while others, such as high-volume hemofiltration, use of high cut-off membranes, non-selective adsorption like coupled plasma filtration adsorption, selective adsorption of endotoxin with polymyxin-B column, are approaches supported by randomized, controlled studies [1,2]. Extracorporeal therapies used to be employed for renal replacement therapy, but can now be used for multiple organ support [2]. Additionally, they can also produce a direct immunomodulation effect by altering the level of inflammatory mediators in the blood, such as cytokines and chemokines, and performing modifications in the complements and coagulation systems [2]. In addition, inhale nitric oxide and immunoglobulin can be used as adjuvant therapies in these patients [3]. Used together with main forms of treatment of sepsis, such as antibiotics, these characteristics make it possible for successful outcomes to be achieved.

Herbal medicine has been used in treating infections and septic shock for a long time. Efficacy of these products for sepsis and septic shock has been partially proven by randomized controlled trials in humans and animals [4]. The active components of these products usually have one or more of the following properties: 1-direct attack and suppression on bacterial pathogens, 2-modulation of the host’s immune system which resulting in suppression of inflammatory response, 3-neutralization of toxic free radicals, 4-lessen of blood glucose level [4]. Si-ni-tang and Baihu Decoction and Baihu with Radix Ginseng are popular ones of them [5,6].

In conclusion, we think that, means permitting, the use in cases of severe sepsis and septic shock of conventional together with adjuvant therapies, particularly extracorporeal procedures and herbal medicine will be beneficial in terms of patient prognosis, and are keenly awaiting the results of continuing research into new treatment modalities and of new studies on the horizon.

References

 

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11801
  • [From(publication date):
    June-2013 - Dec 12, 2017]
  • Breakdown by view type
  • HTML page views : 8002
  • PDF downloads : 3799
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version